Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) – Equities researchers at Zacks Small Cap issued their Q2 2024 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten anticipates that the biopharmaceutical company will earn ($0.21) per share […]
The breast cancer drugs market is expected to grow at a stagnant CAGR of 1.1% from 2022 to 2032, when it is valued at US$ 11,750.33 million. In 2022, the target market is anticipated to be valued US$ 10,637.42 million. The market for breast cancer drugs is expected to grow during the forecast period as a result of f.